Pyrrolo[2,3-D]pyrimidinyl, pyrrolo[2,3-B]pyrazinyl, pyrrolo[2,3-B]pyridinyl acrylamides and epoxides thereof
申请人:Pfizer Inc.
公开号:US10703756B2
公开(公告)日:2020-07-07
The present invention provides pharmaceutically active pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl, and pyrrolo[2,3-b]pyridinyl acrylamides, epoxides, and analogues thereof. Such compounds are useful for inhibiting Janus Kinase (JAK). This invention also is directed to compositions comprising methods for making such compounds, and methods for treating and preventing conditions mediated by JAK.
本发明提供了具有药学活性的吡咯并[2,3-d]嘧啶基、吡咯并[2,3-b]吡嗪基和吡咯并[2,3-b]吡啶基丙烯酰胺、环氧化物及其类似物。此类化合物可用于抑制 Janus 激酶(JAK)。本发明还涉及包含制造此类化合物的方法的组合物,以及治疗和预防由 JAK 介导的病症的方法。